跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 155 条关于
“Hemophagocytic Lymphohistiocytosis”
全部
155
临床试验
110
药物
2
机构
0
资讯
43
去年
ELA026 Granted Orphan Drug Designation by FDA for Hemophagocytic Lymphohistiocytosis
7年前
FDA Approves First Treatment for Primary Hemophagocytic Lymphohistiocytosis, Marking 24-Year Breakthrough
去年
Sobi to Present New Hematology Data at ASH 2024, Highlighting Advances in Rare Blood Disorders
去年
Loncastuximab Tesirine Shows Promise in Treating HLH Associated with DLBCL
去年
FDA Approves Gamifant as First Treatment for Macrophage Activation Syndrome in Still's Disease
9个月前
Electra Therapeutics Advances ELA026 in Pivotal Trial for Rare Blood Disorder sHLH
11个月前
Electra Therapeutics' ELA026 Receives FDA Breakthrough Therapy and EMA Priority Designations for Rare Inflammatory Disease
去年
Ruxolitinib Shows Promise in Treating CAR T-Cell Therapy-Induced Parkinsonism in Multiple Myeloma
2年前
Emapalumab Enhances Intervention-Free Survival in Pediatric HLH Patients Undergoing Stem Cell Transplant
去年
FDA Grants Priority Review for Gamifant in HLH/MAS Associated with Still's Disease
第 1 页，共 5 页
上一页
下一页
